Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 11, 2010, Pages 1657-1660

  Feldmann, Reinhold ^a,b   Schuierer, Gerhard ^a   Wessel, Astrid ^a   Neveling, Nina ^a   Weglage, Josef ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Magnetic resonance imaging; Neurological development

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; BRAIN REGION; CAPSULA INTERNA; CEREBELLUM; CHILD; COGNITION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THALAMUS;

ADOLESCENT; BRAIN; CHILD; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTELLIGENCE TESTS; MAGNETIC RESONANCE IMAGING; MALE; NEUROFIBROMATOSIS 1; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 78649744921     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.01923.x     Document Type: Article

References (30)

1. Huson SM, Hughes RAC. The neurofibromatoses: A pathogenetic and clinical overview. London: Chapman and Hall, 1994.
2. Ruggieri M, Huson SM. The neurofibromatoses. An overview. Ital J Neurol Sci 1999; 20: 89-108.
3. North K. Neurofibromatosis type 1. Am J Med Genet 2000; 97: 119-27.
4. Listernick R, Charrow J. Neurofibromatosis type 1 in childhood. J Pediatr 1990; 116: 845-53.
5. Moore BD, Slopis JM, Jackson EF, De Winter AE, Leeds NE. Brain volume in children with neurofibromatosis type 1. Neurology 2000; 54: 914-20.
6. Hyman SL, Gill SD, Shores EA, Steinberg A, North KN. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning. J Neurol Neurosurg Psychiatr 2007; 78: 1088-91.
7. DiPaolo DP, Zimmerman RA, Rorke LB, Zackai EF, Bilaniuk LT, Yachnis AT. Neurofibromatosis type 1: Pathological substrate of high-signal-intensity foci in the brain. Radiology 1995; 195: 721-4.
8. Van Es S, North KN, McHugh K, De Silva M. MRI findings in children with neurofibromatosis type 1: A prospective study. Pediatr Radiol 1996; 26: 478-87.
9. Sevick RJ, Bartovich AJ, Edwards MSB, Koch T, Berg B, Lempert T. Evolution of white matter lesions in neurofibromatosis type 1: MR findings. Am J Roentgenol 1992; 159: 171-5.
10. Hyman SL, Gill DS, Shores EA, Steinberg A, Joy P, Gibikote SV, et al. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1. Neurology 2003; 60: 1139-45.
11. Duffner PK, Cohen ME, Seidel FG, Shucard DW. The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989; 39: 373-8.
12. North K, Joy P, Yuille D, Cocks N, Mobbs E, Hutchins P, et al. Specific learning disability in children with neurofibromatosis type 1. Neurology 1994; 44: 878-83.
13. Itoh T, Magnaldi S, White RM, Denckla MB, Hofman K, Naidu S, et al. Neurofibromatosis Type 1: The evolution of deep gray and white matter MR abnormalities. Am J Neuroradiol 1994; 15: 1513-9.
14. Ozonoff S. Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 1999; 89: 45-52.
15. Legius E, Descheemaeker MJ, Steyaert J, Spaepen A, Casaer P, Fryns JP. Neurofibromatosis type 1 in childhood: A study of the neuropsychological profile in 45 children. Genet Couns 1994; 5: 51-60.
16. Joy P, Roberts C, North K, de Silva M. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol 1995; 37: 906-14.
17. Denckla MB, Hofman K, Mazzocco MM, Melhem E, Reiss AL, Bryan RN, et al. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 1996; 67: 98-102.
18. Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996; 46: 1660-8.
19. Bawden H, Dooley J, Buckley D, Camfield P, Gordon K. MRI and nonverbal cognitive deficits in children with neurofibromatosis 1. J Clin Exp Neuropsychol 1996; 18: 748-92.
20. Ferner RE, Hughes RAC, Weinman J. Intellectual impairment in neurofibromatosis 1. J Neurol Sci 1996; 138: 125-33.
21. Samango-Sprouse C, Vezina LG, Brasseux C, Tillman S, Tifft CJ. Cranial magnetic resonance findings and the neurodevelopmental performance in the young child with neurofibromatosis type 1. Am J Hum Genet 1996; 61 (Suppl.): 178.
22. Lorch M, Ferner R, Golding J, Whurr R. The nature of speech and language impairment in adults with neurofibromatosis 1. J Neurolinguistics 1999; 12: 157-65.
23. Feldmann R, Denecke J, GrenzebachM, Schuierer G, Weglage J. Neurofibromatosis type 1: Motor cognitive functions and MRI correlates. Neurology 2003; 61: 1725-8.
24. Riccardi VM, Eichner JE. Neurofibromatosis. Phenotype, natural history and pathogenesis. Baltimore: Johns Hopkins University Press, 1986.
25. Zoeller MET, Rembeck B, Baeckman L. Neuropsychological deficits in adults with neurofibromatosis type 1. Acta Neurol Scand 1997; 95: 225-32.
26. National Institutes of Health Consensus Development Conference Statement. Neurofibromatosis. Arch Neurol 1988; 45:575-8.
27. Wechsler D. Wechsler Intelligence Scales for Children - Revised. San Antonio, Texas: The Psychological Corporation, 1974.
28. Wechsler D. Wechsler Adult Intelligence Scale - Revised. Cleveland, Ohio: The Psychological Corporation, 1981.
29. Flynn JR. Massive gains in 14 nations: what IQ tests really measure. Psychol Bull 1987; 101: 171-91.
30. Kraut MA, Gerring JP, Cooper KL, Thompson RE, Denckla MB, Kaufmann WE. Longitudinal evolution of unidentified bright objects in children with neurofibromatosis type 1. Am J Med Genetics A 2004; 129: 113-9.